Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-606-1024
Are you Dr. Hill?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Geoffrey Hill, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with Fred Hutch Cancer Center and UW Medicine/University of Washington Medical Center.
Education & Training
University of Auckland Faculty of Medicine and Health SciencesClass of 2001
Certifications & Licensure
WA State Medical License 2018 - 2025
Publications & Presentations
PubMed
- 1 citationsThe contribution of the monocyte-macrophage lineage to immunotherapy outcomes.Rachael C Adams, Kelli P A MacDonald, Geoffrey R Hill
Blood. 2025-03-06 - Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease.Julie R Boiko, Kathleen S Ensbey, Olivia G Waltner, Isaac C Jenkins, Shruti S Bhise
Blood. 2025-02-20 - Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD.Michael C Zaiken, Sujeong Jin, Cameron McDonald-Hyman, Christina Hartigan, Peter Sage
Blood. 2025-02-03
Press Mentions
Tip Sheet: How a Failed Alzheimer’s Drug Boosts CAR T-cell Therapy; A New Type of Anti-CRISPR; And How GVHD Starts in the GutOctober 2nd, 2019
Grant Support
- Adult Leukemia Research CenterFRED HUTCHINSON CANCER CENTER1997–2029
- Defining Protective CMV Immunity after TransplantationFRED HUTCHINSON CANCER CENTER2023–2028
- Defining Protective CMV Immunity after TransplantationFRED HUTCHINSON CANCER CENTER2023–2028
- Preventing GVHD by inhibition of alloantigen presentation in the gutFRED HUTCHINSON CANCER CENTER2019–2027
